Dipeptidyl Peptidase-4 Inhibitor Prevents the Progression of Heart Failure After Myocardial Infarction

被引：0
|
作者：
Kubota, Akihiko [1 ]
Takano, Hiroyuki [2 ]
Hasegawa, Hiroshi [1 ]
Kobara, Yuka [1 ]
Wang, Haixiu [2 ]
Nagamine, Akari [2 ]
Ono, Ayaka [2 ]
Kameda, Yoshihito [1 ]
Hirose, Masanori [1 ]
Tadokoro, Hiroyuki [3 ]
Kobayashi, Yoshio [1 ]
机构：
[1] Chiba Univ, Grad Sch Med, Dept Cardiovasc Med, Chiba, Japan
[2] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cardiovasc Pharmacol, Chiba, Japan
[3] Tokai Univ, Sch High Technol Human Welf, Dept Biomed Engn, Numazu, Japan
来源：
CIRCULATION | 2013年 / 128卷 / 22期
关键词：
Ischemic heart disease; Pharmacology; Heart failure;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
11421
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Effect of Dipeptidyl Peptidase-4 Inhibitors on Heart Failure: A Network Meta-Analysis
    Guo, Wen-Qin
    Li, Lang
    Su, Qiang
    Dai, Wei-Ran
    Ye, Zi-Liang
    VALUE IN HEALTH, 2017, 20 (10) : 1427 - 1430
  • [32] Risk of myocardial infarction in trials with Dipeptidyl Peptidase-4 inhibitors: Is duration of study a real issue?
    Dicembrini, Ilaria
    Mannucci, Edoardo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 184 : 543 - 544
  • [33] Dipeptidyl peptidase-4 inhibitor-induced bullous pemphigoid
    Reactions Weekly, 2021, 1861 (1) : 9 - 9
  • [34] Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans
    Ahren, B.
    Schweizer, A.
    Dejager, S.
    Villhauer, E. B.
    Dunning, B. E.
    Foley, J. E.
    DIABETES OBESITY & METABOLISM, 2011, 13 (09): : 775 - 783
  • [35] Association between Add-On Dipeptidyl Peptidase-4 Inhibitor Therapy and Diabetic Retinopathy Progression
    Kang, Eugene Yu-Chuan
    Kang, Chunya
    Wu, Wei-Chi
    Sun, Chi-Chin
    Chen, Kuan-Jen
    Lai, Chi-Chun
    Chen, Tien-Hsing
    Hwang, Yih-Shiou
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (13)
  • [36] Bullous pemphigoid associated with use of dipeptidyl peptidase-4 inhibitor
    Kano, Yasuhiro
    Kato, Miyuki
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (34) : E1186 - E1187
  • [37] Dipeptidyl peptidase-4 inhibitor-related renal disease
    Suenaga, Atsuhiko
    Sawa, Naoki
    Oba, Yuki
    Ikuma, Daisuke
    Sekine, Akinari
    Hasegawa, Eiko
    Mizuno, Hiroki
    Suwabe, Tatsuya
    Ikeda, Sara
    Tsujimoto, Tetsuro
    Kono, Kei
    Shintani-Domoto, Yukako
    Kinowaki, Keiichi
    Ohashi, Kenichi
    Miyazono, Motoaki
    Yamaguchi, Yutaka
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (10)
  • [38] Collagenous Colitis Possibly Associated with Dipeptidyl Peptidase-4 Inhibitor
    Takedomi, Hironobu
    Sakata, Yasuhisa
    Tomonaga, Michito
    Naruse, Naomi
    Yukimoto, Takahiro
    Akutagawa, Takashi
    Tsuruoka, Nanae
    Shimoda, Ryo
    Kido, Shinichi
    Esaki, Motohiro
    INTERNAL MEDICINE, 2022, 61 (18) : 2731 - 2734
  • [39] Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition
    Kirby, Mark
    Yu, Denise M. T.
    O'Connor, Stephen P.
    Gorrell, Mark D.
    CLINICAL SCIENCE, 2010, 118 (1-2) : 31 - 41
  • [40] Renoprotective Effect of a Dipeptidyl Peptidase-4 Inhibitor on Aging Mice
    Ban, Tae H.
    Kim, Eun N.
    Kim, Min Y.
    Lim, Ji H.
    Lee, Jong H.
    Kim, Hyung D.
    Yoon, Hye E.
    Park, Cheol W.
    Choi, Bum S.
    AGING AND DISEASE, 2020, 11 (03): : 588 - 602
12345